<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We describe a patient with <z:hpo ids='HP_0004430'>severe combined immunodeficiency</z:hpo> because of aberrations in <z:chebi fb="3" ids="16335">adenosine</z:chebi> deaminase (<z:chebi fb="36" ids="39048">ADA</z:chebi>) who despite adequate replacement with <z:chebi fb="1" ids="46793">polyethylene glycol</z:chebi>-linked <z:chebi fb="36" ids="39048">ADA</z:chebi> (<z:chebi fb="77" ids="46793">PEG</z:chebi>-<z:chebi fb="36" ids="39048">ADA</z:chebi>) for 13 years developed Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Although treatment corrected the <z:mp ids='MP_0005266'>metabolic abnormalities</z:mp> caused by <z:chebi fb="36" ids="39048">ADA</z:chebi> deficiency, it failed to fully restore cellular immunity </plain></SENT>
</text></document>